NCT00513526 2023-11-14
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
AIDS Malignancy Consortium
Phase 2 Completed
Clinical Trials
12 trialsNCT00873288 2023-03-21
Activating Collaborative CIS Support Via Targeted Provider Mailing
Northwestern University
Phase NA Completed
NCT00896480 2021-04-08
Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma
GlaxoSmithKline
Phase 2 Completed
NCT01149343 2020-11-20
Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer
GlaxoSmithKline
Phase 1 Completed
NCT01550783 2020-07-31
Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening
University of Washington
Phase NA Completed
NCT03903952 2019-04-05
Can B12 and Folate Levels Predict HPV Penetration in Patients With ASCUS?
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Phase NA Completed
NCT03372395 2017-12-13
Probiotic Implementation as Help in Solving Vaginal Infections
University of Roma La Sapienza
Phase 2 Completed
NCT00973362 2017-01-06
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
Gen-Probe, Incorporated
Phase 3 Completed
NCT00653146 2016-12-05
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Fox Chase Cancer Center
Phase NA Completed
NCT00703196 2015-10-08
Folic Acid Clinical Trial for the Prevention of Cervical Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT00458562 2013-11-19
Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer
University of Washington
Completed
NCT00091130 2013-06-03
SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells
National Cancer Institute (NCI)
Phase 2 Completed